Cited by 1,301Pluripotent Stem Cells ResearchDevelopmental Biology and Gene RegulationNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

Open access

Hong, Hyenjong, Takahashi, Kazutoshi, Ichisaka, Tomoko, Aoi, Takashi, Kanagawa, Osami, Nakagawa, Masato, Okita, Keisuke, Yamanaka, Shinya·2009·Nature

DOI 10.1038/nature08235PMC PMC2917235

Open this paper in CoChat — free account

Abstract

Induced pluripotent stem (iPS) cells can be generated from somatic cells by the introduction of Oct3/4 (also known as Pou5f1), Sox2, Klf4 and c-Myc, in mouse and in human. The efficiency of this process, however, is low. Pluripotency can be induced without c-Myc, but with even lower efficiency. A p53 (also known as TP53 in humans and Trp53 in mice) short-interfering RNA (siRNA) was recently shown to promote human iPS cell generation, but the specificity and mechanisms remain to be determined. Here we report that up to 10% of transduced mouse embryonic fibroblasts lacking p53 became iPS cells, even without the Myc retrovirus. The p53 deletion also promoted the induction of integration-free mouse iPS cells with plasmid transfection. Furthermore, in the p53-null background, iPS cells were generated from terminally differentiated T lymphocytes. The suppression of p53 also increased the efficiency of human iPS cell generation. DNA microarray analyses identified 34 p53-regulated genes that are common in mouse and human fibroblasts. Functional analyses of these genes demonstrate that the p53-p21 pathway serves as a barrier not only in tumorigenicity, but also in iPS cell generation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature08235

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citation
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citation
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438
Self-citation
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R. K., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,732
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Self-citation
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,056
Self-citation
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Plat-E: an efficient and stable system for transient packaging of retroviruses
MORITA, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660

Flagged first, then by citations

Show all 23 references

Sorted by citations

Items 801–900 of 1,003

Structurally-Discovered KLF4 Variants Accelerate and Stabilize Reprogramming to Pluripotency
Borisova, E., Nishimura, K., An, Y., Takami, M., Li, J., Song, D., Matsuo‐Takasaki, M., Luijkx, D. G., Aizawa, S., Kuno, A., et al. (2020) · iScience · doi:10.1016/j.isci.2021.103525 · Cited by 16
Analysis of the REL, BCL11A, and MYCN proto‐oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia
Deambrogi, C., Paoli, L. D., Fangazio, M., Cresta, S., Rasi, S., Spina, V., Gattei, V., Gaïdano, G., & Rossi, D. (2010) · American Journal of Hematology · doi:10.1002/ajh.21742 · Cited by 16
Epigenetics of Pluripotent Cells
Medvedev, S. P., Pokushalov, E. A., & Zakian, S. M. (2012) · Acta Naturae · doi:10.32607/20758251-2012-4-4-28-46 · Cited by 16
p53: A New Kingpin in the Stem Cell Arena
Aparicio, S. A. J. R., & Eaves, C. J. (2009) · Cell · doi:10.1016/j.cell.2009.09.004 · Cited by 16
p53-based Anti-cancer Therapies: an Empty Promise?
Desilet, N., Campbell, T. N., & Choy, F. Y. M. (2010) · Current Issues in Molecular Biology · doi:10.21775/cimb.012.143 · Cited by 16
The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application
Yamada, Y., & Yamada, Y. (2018) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.94.016 · Cited by 18
Generation of Induced Pluripotent Stem Cells with Substitutes for Yamanaka's Four Transcription Factors
Xiao, X., Li, N., Zhang, D., Yang, B. K., Guo, H., & Li, Y. (2016) · Cellular Reprogramming · doi:10.1089/cell.2016.0020 · Cited by 16
The Janus face of pluripotent stem cells – Connection between pluripotency and tumourigenicity
Wobus, A. M. (2010) · BioEssays · doi:10.1002/bies.201000065 · Cited by 15
p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation
Pinnamaneni, J. P., Singh, V., Kim, M. B., Ryan, C. T., Pugazenthi, A., Sanagasetti, D., Mathison, M. N., Yang, J., & Rosengart, T. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-15559-y · Cited by 15
Metabolic control of induced pluripotency
Sinenko, S. A., & Tomilin, A. N. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1328522 · Cited by 15
Mesenchymal stem cells in craniofacial reconstruction: a comprehensive review
Zheng, Z., Liu, H., Liu, S., Luo, E., & Liu, X. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1362338 · Cited by 16
Kinetic Analysis of Porcine Fibroblast Reprogramming Toward Pluripotency by Defined Factors
Cheng, D., Li, Z., Liu, Y., Gao, Y., & Wang, H. (2012) · Cellular Reprogramming · doi:10.1089/cell.2012.0025 · Cited by 15
Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy
Watarai, H., Yamada, D., Fujii, S., Taniguchi, M., & Koseki, H. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1091-0 · Cited by 15
Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case–control study
Zhang, Y., Liu, L., Tang, Y., Chen, C., Wang, Q., Xu, J., Yang, C., Miao, X., Wei, S., Chen, J., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1831-5 · Cited by 15
Can controlled cellular reprogramming be achieved using microRNAs?
Sun, X., Fu, X., Han, W., Zhao, Y., & Liu, H. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.06.002 · Cited by 15
Genome-wide profiling and differential expression of microRNA in rat pluripotent stem cells
Sherstyuk, V. V., Medvedev, S. P., Elisaphenko, E. A., Vaskova, E. A., Ri, M. T., Vyatkin, Y. V., Saik, O. V., Shtokalo, D. N., Pokushalov, E. A., & Zakian, S. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02632-0 · Cited by 15
Implications of Cellular Aging in Cardiac Reprogramming
Passaro, F., & Testa, G. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00043 · Cited by 15
Role of Senescence in Tumorigenesis and Anticancer Therapy
Stoczyńska-Fidelus, E., Węgierska, M., Kierasińska, A., Ciunowicz, D., & Rieske, P. (2022) · Journal of Oncology · doi:10.1155/2022/5969536 · Cited by 15
Tet1 Suppresses p21 to Ensure Proper Cell Cycle Progression in Embryonic Stem Cells
Chrysanthou, S., Flores, J. C., & Dawlaty, M. M. (2022) · Cells · doi:10.3390/cells11081366 · Cited by 15
Expression profiling and pathway analysis of Krüppel-like factor 4 in mouse embryonic fibroblasts.
Hagos, E. G., Ghaleb, A. M., Kumar, A., Neish, A. S., & Yang, V. W. (2011) · PubMed Central · Cited by 15
Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins
Vilas, J. M., Ferreirós, A., Carneiro, C., Morey, L., Silva‐Álvarez, S. D., Fernandes, T., Abad, M., Croce, L. D., García‐Caballero, T., Serrano, M., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2996 · Cited by 15
The assessment of human organic cation transporter 1 (hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population
Ráčil, Z., Rázga, F., Burešová, L., Jurček, T., Dvořáková, D., Žáčková, D., Timilsina, S., Cetkovský, P., & Mayer, J. (2010) · American Journal of Hematology · doi:10.1002/ajh.21722 · Cited by 15
Identification and characterisation of Emp53, the homologue of human tumor suppressor p53, from Echinococcus multilocularis: its role in apoptosis and the oxidative stress response
Cheng, Z., Zhu, S., Wang, L., Liu, F., Tian, H., Pengsakul, T., & Wang, Y. (2015) · International Journal for Parasitology · doi:10.1016/j.ijpara.2015.02.010 · Cited by 15
Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions
Zhang, W., Zhong, L., Wang, J., & Han, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158655 · Cited by 15
Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy
Patel, S. J., Yamauchi, T., & Ito, F. (2019) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2019.02.005 · Cited by 16
Somatic Lineage ReprogrammingPreprint
Shelby, H., Shelby, T., & Wernig, M. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040808 · Cited by 15
Células madre tumorales: una diana terapéutica en el cáncer de mama
Eguiara, A., Elorriaga, K., Rezola, R., & Martín, Á. G. (2012) · Revista de Senología y Patología Mamaria · doi:10.1016/s0214-1582(12)70024-5 · Cited by 14
Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer
Chu, P., Hou, M., Lai, J.-C., Chen, L.-F., & Lin, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081827 · Cited by 14
BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks
Georgieva, D., Wang, N., Taglialatela, A., Jerabek, S., Reczek, C. R., Lim, P. X., Sung, J., Du, Q., Horiguchi, M., Jasin, M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114006 · Cited by 14
Generation of iPSCs from Genetically Corrected Brca2 Hypomorphic Cells: Implications in Cell Reprogramming and Stem Cell Therapy
Navarro, S., Moleiro, V., Molina-Estévez, F. J., Lozano, M. L., Chinchon, R., Almarza, E., Bustamante, O. Q., Mostoslavsky, G., Maetzig, T., Galla, M., et al. (2013) · Stem Cells · doi:10.1002/stem.1586 · Cited by 14
Hematopoietic differentiation from human ESCs as a model for developmental studies and future clinical translations. Invited review following the FEBS Anniversary Prize received on 5 July 2009 at the 34th FEBS Congress in Prague
Moreno, I., Ledran, M. H., & Lako, M. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07926.x · Cited by 14
Natural and artificial routes to pluripotency
Krueger, W. H., Swanson, L. C., Tanasijevic, B., & Rasmussen, T. P. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103199wk · Cited by 16
Xenopatients 2.0: Reprogramming the epigenetic landscapes of patient-derived cancer genomes
Menéndez, J. A., Alarcón, T., Corominas-Faja, B., Cuyàs, E., López‐Bonet, E., Martín, Á. G., & Vellón, L. (2014) · Cell Cycle · doi:10.4161/cc.27770 · Cited by 14
Mechanisms for enhancing cellular reprogramming
Soufi, A. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.007 · Cited by 14
Understanding impediments to cellular conversion to pluripotency by assessing the earliest events in ectopic transcription factor binding to the genome
Soufi, A., & Zaret, K. S. (2013) · Cell Cycle · doi:10.4161/cc.24663 · Cited by 14
Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering
Jung, M., Dunbar, C. E., & Winkler, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.180 · Cited by 14
Integrating Gene Correction in the Reprogramming and Transdifferentiation Processes: A One‐Step Strategy to Overcome Stem Cell‐Based Gene Therapy Limitations
Lee, S., & Chung, S. (2016) · Stem Cells International · doi:10.1155/2016/2725670 · Cited by 14
Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming
Schmitt, C. E., Morales, B. M., Schmitz, E. M. H., Hawkins, J. S., Lizama, C. O., Zape, J. P., Hsiao, E. C., & Zovein, A. C. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0581-7 · Cited by 14
Autonomous xenogenic cell fusion of murine and chick skeletal muscle myoblasts
Takaya, T., Nihashi, Y., Kojima, S., Ono, T., & KAGAMI, H. (2017) · Animal Science Journal · doi:10.1111/asj.12884 · Cited by 14
Comparison of two different culture conditions for derivation of early hiPSC
Hey, C. A. B., Saltõkova, K. B., Bisgaard, H. C., & Møller, L. B. (2018) · Cell Biology International · doi:10.1002/cbin.10966 · Cited by 14
Utilization of Rosmarinic and Ascorbic Acids for Maturation Culture Media in Order to Increase Sow Oocyte Quality Prior to IVF
Boldura, O. M., Marc, S., Otavă, G., Huțu, I., Baltă, C., Tulcan, C., & MIRCU, C. (2021) · Molecules · doi:10.3390/molecules26237215 · Cited by 14
Antitumor effect of Escherichia coli-derived outer membrane vesicles on neuroblastoma in vitro and in vivo
Jin, L., Zhang, Z., Tan, X., Wang, Z., Tang, B., Wang, Z., Li, M., Mi, T., Shen, L., Long, C., et al. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022127 · Cited by 14
Reprogramming somatic cells to pluripotency: A fresh look at Yamanaka’s model
Li, Y., Shen, Z., Shelat, H. S., & Geng, Y. (2013) · Cell Cycle · doi:10.4161/cc.26952 · Cited by 14
Induced Neural Stem Cells Generated from Rat Fibroblasts
Xi, G., Hu, P., Qu, C., Qiu, S., Tong, C., & Ying, Q.-L. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.09.003 · Cited by 14
Human pluripotent stem cells: from biology to cell therapy.
Ramirez, J.-M., Bai, Q., Dijon-Grinand, M., Assou, S., Gerbal-Chaloin, S., Hamamah, S., & de Vos, J. (2010) · World Journal of Stem Cells · doi:10.4252/wjsc.v2.i2.24 · Cited by 15
p53: The Barrier or Guardian for Cell Dedifferentiation?
Pan, Y., Cai, S., Fu, X., & Andong, Z. (2014) · BioScience · doi:10.1093/biosci/biu133 · Cited by 14
A protocol to assess cell cycle and apoptosis in human and mouse pluripotent cells
Edel, M. J., Menchón, C., Vaquero, J. A., & Belmonte, J.-C. I. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-8 · Cited by 14
The cell cycle as a brake for β-cell regeneration from embryonic stem cells
El-Badawy, A., & El‐Badri, N. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0274-z · Cited by 14
p63 Silencing induces reprogramming of cardiac fibroblasts into cardiomyocyte-like cells
Patel, V. B., Singh, V., Pinnamaneni, J. P., Sanagasetti, D., Olive, J. K., Mathison, M. N., Cooney, A. J., Flores, E. R., Crystal, R. G., Yang, J., et al. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.03.162 · Cited by 14
Immortalized murine fibroblast cell lines are refractory to reprogramming to pluripotent state
Skvortsova, E. V., Sinenko, S. A., & Tomilin, A. N. (2018) · Oncotarget · doi:10.18632/oncotarget.26235 · Cited by 14
Protein expression-based classification of gastric cancer by immunohistochemistry of tissue microarray
Zhao, C., Feng, Z., He, H., Zang, D., Du, H., Huang, H., Du, Y., He, J., Zhou, Y., & Nie, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238836 · Cited by 14
Senescent Cells in IPF: Locked in Repair?
Meiners, S., & Lehmann, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.606330 · Cited by 14
Potential of Human Induced Pluripotent Stem Cells Derived from Blood and Other Postnatal Cell Types
Ye, Z., & Cheng, L. (2010) · Regenerative Medicine · doi:10.2217/rme.10.38 · Cited by 14
Enhanced generation of human induced pluripotent stem cells by ectopic expression of Connexin 45
Ke, Q., Li, L., Yao, X., Lai, X., Cai, B., Chen, H., Chen, R., Zhai, Z., Huang, L., Li, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00523-y · Cited by 14
Absence of cyclin-dependent kinase inhibitor p27 or p18 increases efficiency of iPSC generation without induction of iPSC genomic instability
Zhan, Z., Song, L., Zhang, W., Gu, H., Cheng, H., Zhang, Y., Yang, Y., Ji, G., Feng, H., Cheng, T., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1502-8 · Cited by 14
Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition
Pan, Y., Gu, Z., Lyu, Y., Yang, Y., Chung, M., Pan, X., & Cai, S. (2022) · Rejuvenation Research · doi:10.1089/rej.2022.0021 · Cited by 15
Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia
Müller, L., Schlaeger, T. M., DeVine, A. L., & Williams, D. A. (2012) · Cell Cycle · doi:10.4161/cc.21109 · Cited by 13
Embryonic stem cells and inducible pluripotent stem cells: two faces of the same coin?
Romeo, F., Costanzo, F. S., & Agostini, M. (2012) · Aging · doi:10.18632/aging.100513 · Cited by 15
New Insights into Cell Cycle Regulation and DNA Damage Response in Embryonic Stem Cells
Suvorova, I. I., Katolikova, N. V., & Pospelov, V. A. (2012) · International review of cytology · doi:10.1016/b978-0-12-394310-1.00004-7 · Cited by 14
Induced Pluripotent Stem Cells (iPSCs): An Emerging Model System for the Study of Human Neurotoxicology
Neely, M. D., Tidball, A. M., Aboud, A. A., Ess, K. C., & Bowman, A. B. (2011) · Neuromethods · doi:10.1007/978-1-61779-077-5_2 · Cited by 13
Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors
Thornton, C. D., Fielding, S., Karbowniczek, K., Roig‐Merino, A., Burrows, A. E., FitzPatrick, L. M., Sharaireh, A. M., Tite, J. P., Mole, S., Harbottle, R. P., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.018 · Cited by 13
Generation of Parthenogenetic Induced Pluripotent Stem Cells from Parthenogenetic Neural Stem Cells
Tae, J., Joo, J. Y., Han, D., Araúzo-Bravo, M. J., Kim, M. J., Greber, B., Zaehres, H., Sobek-Klocke, I., Chung, H., & Schöler, H. R. (2009) · Stem Cells · doi:10.1002/stem.233 · Cited by 13
Current Progress and Potential Practical Application for Human Pluripotent Stem Cells
Philonenko, E. S., Shutova, M. V., Chestkov, I. V., Lagarkova, M. A., & Киселев, С. Л. (2011) · International review of cytology · doi:10.1016/b978-0-12-386033-0.00004-9 · Cited by 13
Telomere dynamics in induced pluripotent stem cells: Potentials for Human disease modeling
Ly, H. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i10.89 · Cited by 14
p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations
Lao, X., Chen, Z., & Qin, A. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3923-7 · Cited by 13
Chemische Kontrolle des Schicksals und Entwicklungspotenzials von Stammzellen
Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., & Schultz, P. G. (2010) · Angewandte Chemie · doi:10.1002/ange.201004284 · Cited by 13
The CCR4-NOT deadenylase activity contributes to generation of induced pluripotent stem cells
Zukeran, A., Takahashi, A., Takaoka, S., Mohamed, H. M. A., Suzuki, T., Ikematsu, S., & Yamamoto, T. S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.119 · Cited by 13
Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency
Ferreirós, A., Pedrosa, P., Silva‐Álvarez, S. D., Triana-Martínez, F., Vilas, J. M., Picallos-Rabina, P., González, P., Gómez, M., Li, H., García‐Caballero, T., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.04.006 · Cited by 13
Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion
Tanabe, K., Nobuta, H., Yang, N., Ang, C. E., Huie, P., Jordan, S., Oldham, M. C., Rowitch, D. H., & Wernig, M. (2022) · Development · doi:10.1242/dev.199723 · Cited by 13
Genetic engineering of rotaviruses by reverse genetics
Komoto, S., & Taniguchi, K. (2013) · Microbiology and Immunology · doi:10.1111/1348-0421.12071 · Cited by 13
Helpers of the cellular gatekeeper—miRNAs dance in P53 network
Shi, M., Liu, D., Shen, B., & Guo, N. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.12.001 · Cited by 13
Bridges between Cell Cycle Regulation and Self-Renewal Maintenance
Viatour, P. (2012) · Genes & Cancer · doi:10.1177/1947601913481355 · Cited by 13
Reprogramming of Embryonic Human Fibroblasts into Fetal Hematopoietic Progenitors by Fusion with Human Fetal Liver CD34+ Cells
Sandler, V. M., Lailler, N., & Bouhassira, E. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018265 · Cited by 12
SYK is a target of lymphocyte-derived microparticles in the induction of apoptosis of human retinoblastoma cells
Qiu, Q., Yang, C., Xiong, W., Tahiri, H., Payeur, M., Superstein, R., Carret, A., Hamel, P., Ellezam, B., Bussières, M., et al. (2015) · APOPTOSIS · doi:10.1007/s10495-015-1177-2 · Cited by 12
Synthetic Retinoid Kills Drug‐Resistant Cancer Stem Cells via Inducing RARγ‐Translocation‐Mediated Tension Reduction and Chromatin Decondensation
Zhang, Y., Dong, Q., An, Q., Zhang, C., Mohagheghian, E., Niu, B., Qi, F., Wei, F., Chen, S., Chen, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202203173 · Cited by 12
BNIP3-dependent mitophagy safeguards ESC genomic integrity via preventing oxidative stress-induced DNA damage and protecting homologous recombination
Zhao, Q., Liu, K., Zhang, L., Li, Z., Wang, L., Cao, J., Xu, Y., Zheng, A., Chen, Q., & Zhao, T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05413-4 · Cited by 12
YO2 Induces Melanoma Cell Apoptosis through p53-Mediated LRP1 Downregulation
Salama, Y., Takahashi, S., Tsuda, Y., Okada, Y., Hattori, K., & Heissig, B. (2022) · Cancers · doi:10.3390/cancers15010288 · Cited by 12
mRNA-based generation of marmoset PGCLCs capable of differentiation into gonocyte-like cells
Kubiura‐Ichimaru, M., Penfold, C. A., Kojima, K., Dollet, C., Yabukami, H., Semi, K., Takashima, Y., Boroviak, T., Kawaji, H., Woltjen, K., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.08.006 · Cited by 12
Regulation of self-renewal and reprogramming by TCF factors
Ombrato, L., Lluı́s, F., & Cosma, M. P. (2012) · Cell Cycle · doi:10.4161/cc.11.1.18759 · Cited by 13
Current protocols in the generation of pluripotent stem cells: theoretical, methodological and clinical considerations
Swelstad, B. B., & Kerr, C. L. (2009) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s8051 · Cited by 12
Mechanism and methods to induce pluripotency
Wang, P., & Na, J. (2011) · Protein & Cell · doi:10.1007/s13238-011-1107-1 · Cited by 13
PHLDA3 impedes somatic cell reprogramming by activating Akt-GSK3β pathway
Qiao, M., Wu, M., Shi, R., & Hu, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-02982-9 · Cited by 12
Asymmetric cell division and replicative aging: a new perspective from the spindle poles
Manzano‐Lopez, J., & Monje-Casas, F. (2020) · Current Genetics · doi:10.1007/s00294-020-01074-y · Cited by 12
Targeting cancer stem cells in refractory cancer
Miyoshi, N., Haraguchi, N., Mizushima, T., Ishii, H., Yamamoto, H., & Mori, M. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.01.002 · Cited by 12
Noise Cancellation: Viral Fine Tuning of the Cellular Environment for Its Own Genome Replication
Sato, Y., & Tsurumi, T. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001158 · Cited by 12
SIRT2 is required for efficient reprogramming of mouse embryonic fibroblasts toward pluripotency
Kim, A.-Y., Lee, E., Lee, E. H., Kim, J., Suk, K., Lee, E., Hur, K., Hong, Y. J., Tae, J., Park, S., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0920-3 · Cited by 12
Cancer‐associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17
Srivastava, Y., Tan, D. S., Malik, V., Weng, M., Javed, A., Cojocaru, V., Wu, G., Veerapandian, V., Cheung, L. W. T., & Jauch, R. (2019) · FEBS Journal · doi:10.1111/febs.15076 · Cited by 12
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
Reyes, J., Priore, I. S. D., Chaikovsky, A. C., Pasnuri, N., Elhossiny, A. M., Park, J., Weiler, P., Krause, T., Moorman, A. R., Snopkowski, C., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.032 · Cited by 12
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 12
A poor imitation of a natural process
Zhang, Y., Yao, L., Yu, X., Ou, J., Ning, H., & Liu, S. (2012) · Cell Cycle · doi:10.4161/cc.22575 · Cited by 11
FANCA knockout in human embryonic stem cells causes a severe growth disadvantage
Vanuytsel, K., Cai, Q., Nair, N., Khurana, S., Shetty, S., Vermeesch, J. R., Ordovás, L., & Verfaillie, C. M. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.07.005 · Cited by 11
Retracted
Senescence Mediated by p16INK4a Impedes Reprogramming of Human Corneal Endothelial Cells into Neural Crest Progenitors
Lu, W., Tseng, S. C. G., Chen, S., Tighe, S. P., Zhang, Y., Liu, X., Chen, S., Su, C., & Zhu, Y. (2016) · Scientific Reports · doi:10.1038/srep35166 · Cited by 11
Charting a high-resolution roadmap for regeneration of pancreatic β cells by in vivo transdifferentiation from adult acinar cells
Liu, G., Li, Y., Li, M., Li, S., He, Q. H., Liu, S., Su, Q., Chen, X., Xu, M., Zhang, Z., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg2183 · Cited by 11
Cdkn1a deletion or suppression by cyclic stretch enhance the osteogenic potential of bone marrow mesenchymal stem cell-derived cultures
Juran, C. M., Žvirblytė, J., Cheng-Campbell, M., Blaber, E. A., & Almeida, E. A. C. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102513 · Cited by 12
Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming
Oh, H., Kim, J., & Kim, J. (2016) · FEBS Journal · doi:10.1111/febs.13941 · Cited by 11
Labor Pains of New Technology
Yoshida, Y., & Yamanaka, S. (2012) · Circulation Research · doi:10.1161/circresaha.112.271445 · Cited by 11
Self-citation
Calcineurin‐NFAT Signaling Controls Somatic Cell Reprogramming in a Stage‐Dependent Manner
Sun, M., Liao, B., Tao, Y., Chen, H., Xiao, F., Gu, J., Gao, S., & Jin, Y. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25212 · Cited by 10
Quantitative Proteomic Analysis of Mouse Embryonic Fibroblasts and Induced Pluripotent Stem Cells Using 16O/18O Labeling
Huang, X., Tian, C., Liu, M., Wang, Y., Tolmachev, A. V., Sharma, S., Yu, F., Fu, K., Zheng, J., & Ding, S. (2012) · Journal of Proteome Research · doi:10.1021/pr300155r · Cited by 10
The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming
Shoae‐Hassani, A., Sharif, S., & Verdi, J. (2011) · Cell Biology International · doi:10.1042/cbi20100927 · Cited by 10
5-Azacytidine pretreatment confers transient upregulation of proliferation and stemness in human mesenchymal stem cells
Ong, A. L. C., Lee, S. H., Aung, S. W., Khaing, S. L., & Ramasamy, T. S. (2021) · Cells and Development · doi:10.1016/j.cdev.2021.203659 · Cited by 10

Authors: Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S.
Affiliations: Kyoto University (JP)
RIKEN (JP)
Gladstone Institutes (US)
Corresponding author: Yamanaka, Shinya
ORCID: Takahashi, Kazutoshi
Aoi, Takashi
Kanagawa, Osami
Nakagawa, Masato
Okita, Keisuke
Yamanaka, Shinya
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2009-08
Volume: 460
Issue: 7259
Pages: 1132-1135
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature08235
PMC: PMC2917235
OpenAlex: W2081620485
Cited by: 1,301
References: 23
Citations by year: 2026: 13 · 2025: 16 · 2024: 25 · 2023: 29 · 2022: 44 · 2021: 51 · 2020: 41 · 2019: 56 · 2018: 63 · 2017: 59 · 2016: 78 · 2015: 88 · 2014: 116 · 2013: 117 · 2012: 168
FWCI: 67.71
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
Funders: National Heart, Lung, and Blood Institute (U01HL100406)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: induced pluripotent stem cells, p53, p21, p53/p21 pathway, reprogramming efficiency, mouse embryonic fibroblasts, T cells, plasmid transfection, p53 target genes, tumorigenicity, Oct4, SOX2, KLF4, c-Myc
MeSH terms: Kruppel-Like Factor 4, Adult, Animals, Cell Differentiation, Embryo, Mammalian, Female, Fibroblasts, Humans, Male, Plasmids, T-Lymphocytes, Transfection, Tumor Suppressor Protein p53, Genes, myc, Oligonucleotide Array Sequence Analysis, Gene Silencing, Gene Expression Profiling, Pluripotent Stem Cells, Cyclin-Dependent Kinase Inhibitor p21, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Suppression of induced pluripotent stem cell generation by the p53–p21 pathway

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks